Drug Profile
Nicorandil - Chugai Pharmaceutical
Alternative Names: SG-75; SigmartLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Chugai Pharmaceutical
- Class Ischaemic heart disorder therapies; Nitrates; Small molecules; Vasodilators
- Mechanism of Action KATP channel stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Angina pectoris; Heart failure
Most Recent Events
- 29 Aug 2017 Chemical structure information added